Found: 4
Select item for more details and to access through your institution.
Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-02886-1
- By:
- Publication type:
- Article
Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12173-1
- By:
- Publication type:
- Article
Current status and progress of PD-L1 detection: guiding immunotherapy for non-small cell lung cancer.
- Published in:
- Clinical & Experimental Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1007/s10238-024-01404-1
- By:
- Publication type:
- Article
The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer.
- Published in:
- MedComm, 2024, v. 5, n. 6, p. 1, doi. 10.1002/mco2.604
- By:
- Publication type:
- Article